Brain

Genetic risk and stressful early infancy join to increase risk for schizophrenia

Working with genetically engineered mice and the genomes of thousands of people with schizophrenia, researchers at Johns Hopkins say they now better understand how both nature and nurture can affect one's risks for schizophrenia and abnormal brain development in general.

The researchers reported in the March 2 issue of Cell that defects in a schizophrenia-risk genes and environmental stress right after birth together can lead to abnormal brain development and raise the likelihood of developing schizophrenia by nearly one and half times.

Study suggests new way to treat chronic pain

Nearly one in five people suffers from the insidious and often devastating problem of chronic pain.

That the problem persists, and is growing, is striking given the many breakthroughs in understanding the basic biology of pain over the past two decades. A major challenge for treating chronic pain is to understand why certain people develop pain while others, with apparently similar disorders or injuries, do not. An equally important challenge is to develop individualized therapies that will be effective in specific patient populations.

Dare you protest against God? Perspectives from a CWRU psychology study

Is it OK to protest God's actions—or inactions? This was the key question behind recent studies led by Case Western Reserve University psychologist Julie Exline.

Many people report having a relationship with God, similar to those relationships in marriage, parenting or friendship. Exline and colleagues found that being assertive with God could actually strengthen that perceived bond and one's faith.

The brains behind skaters

A new study, using brain imaging technology, reveals structural adaptations in short-track speed skaters' brains which are likely to explain their extraordinary balance and co-ordination skills. The work by Im Joo Rhyu from the Korea University College of Medicine, and colleagues, is published online in Springer's journal Cerebellum.

Popcorn: the snack with even higher antioxidant levels than fruits and vegetables

SAN DIEGO, March 25, 2012 — Popcorn's reputation as a snack food that's actually good for health popped up a few notches today as scientists reported that it contains more of the healthful antioxidant substances called "polyphenols" than fruits and vegetables. They spoke at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, being held here this week.

Interventional radiologists see 'significant' symptom relief in MS patients

Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.

Highly flexible despite hard-wiring -- even slight stimuli change the information flow in the brain

Stroke Progress Review Group sets priorities for future NIH stroke rehabilitation research

West Orange, NJ. March 23, 2012. In 2011, the National Institute of Neurological Disorders and Stroke (NINDS) convened the Stroke Progress Review Group (SPRG) to conduct a final 10-year review of the state of stroke research. The goal is to set priorities and shape future NINDS programs and policies. While SPRG found much available data for maximizing stroke rehabilitation outcomes, translation to clinical practice is inadequate.

Possible causes of sudden onset OCD in kids broadened

Criteria for a broadened syndrome of acute onset obsessive compulsive disorder (OCD) have been proposed by a National Institutes of Health scientist and her colleagues. The syndrome, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), includes children and teens that suddenly develop on-again/off-again OCD symptoms or abnormal eating behaviors, along with other psychiatric symptoms – without any known cause.

Learning best when you rest: Sleeping after processing new info most effective, new study shows

Nodding off in class may not be such a bad idea after all. New research from the University of Notre Dame shows that going to sleep shortly after learning new material is most beneficial for recall,

Titled "Memory for Semantically Related and Unrelated Declarative Information:The Benefit of Sleep, the Cost of Wake," the study was published March 22 in PLOS One.

A new test might facilitate diagnosis and drug development for Alzheimer's disease

An international team of researchers have developed a new method for measurement of aggregated beta-amyloid – a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.

Brain insulin resistance contributes to cognitive decline in Alzheimer's disease

PHILADELPHIA – Insulin resistance in the brain precedes and contributes to cognitive decline above and beyond other known causes of Alzheimer's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Insulin is an important hormone in many bodily functions, including the health of brain cells. The team identified extensive abnormalities in the activity of two major signaling pathways for insulin and insulin-like growth factor in non-diabetic people with Alzheimer's disease.

Experts challenge FDA over approval for new dose of Alzheimer's drug

Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts on bmj.com today.

In the first of a new occasional series, "not so", highlighting the exaggerations, distortions, and selective reporting that mark some news stories, advertising, and medical journal articles, Lisa M. Schwartx and Steven Woloshin challenge the claims made for the new 23 mg dose of donepezil.

Gene expression abnormalities in autism identified

A study led by Eric Courchesne, PhD, director of the Autism Center of Excellence at the University of California, San Diego School of Medicine has, for the first time, identified in young autism patients genetic mechanisms involved in abnormal early brain development and overgrowth that occurs in the disorder. The findings suggest novel genetic and molecular targets that could lead to discoveries of new prevention strategies and treatment for the disorder.

Somatic stem cells obtained from skin cells for first time ever